ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC38877-5mg |
|
1214672-15-7 |
(Rac)-LM11A-31 dihydrochloride
|
0 | C12H27Cl2N3O2 | |
GC38876-100mg |
|
2166616-74-4 |
(Rac)-IDO1-IN-5
|
0 | C23H25FN2O3 | |
GC38876-50mg |
|
2166616-74-4 |
(Rac)-IDO1-IN-5
|
0 | C23H25FN2O3 | |
GC38876-25mg |
|
2166616-74-4 |
(Rac)-IDO1-IN-5
|
0 | C23H25FN2O3 | |
GC38876-10mg |
|
2166616-74-4 |
(Rac)-IDO1-IN-5
|
0 | C23H25FN2O3 | |
GC38876-5mg |
|
2166616-74-4 |
(Rac)-IDO1-IN-5
|
0 | C23H25FN2O3 | |
GC38875-25mg |
|
1258641-38-1 |
(Rac)-ABT-202 dihydrochloride
|
0 | C9H15Cl2N3 | |
GC38875-10mg |
|
1258641-38-1 |
(Rac)-ABT-202 dihydrochloride
|
0 | C9H15Cl2N3 | |
GC38875-5mg |
|
1258641-38-1 |
(Rac)-ABT-202 dihydrochloride
|
0 | C9H15Cl2N3 | |
GC38875-1mg |
|
1258641-38-1 |
(Rac)-ABT-202 dihydrochloride
|
0 | C9H15Cl2N3 | |
GC38874-10mg |
|
55399-93-4 |
(2S,3R,4S)-4-Hydroxyisoleucine
|
0 | C6H13NO3 | |
GC38874-5mg |
|
55399-93-4 |
(2S,3R,4S)-4-Hydroxyisoleucine
|
0 | C6H13NO3 | |
GC38873-10mg |
|
— |
α2β1 Integrin Ligand Peptide TFA
|
0 | C16H23F3N4O11 | |
GC38873-5mg |
|
— |
α2β1 Integrin Ligand Peptide TFA
|
0 | C16H23F3N4O11 | |
GC38873-1mg |
|
— |
α2β1 Integrin Ligand Peptide TFA
|
0 | C16H23F3N4O11 | |
GC38872-10mg |
|
863406-85-3 |
Zoniporide hydrochloride hydrate
|
0 | C17H19ClN6O2 | |
GC38872-5mg |
|
863406-85-3 |
Zoniporide hydrochloride hydrate
|
0 | C17H19ClN6O2 | |
GC38872-1mg |
|
863406-85-3 |
Zoniporide hydrochloride hydrate
|
0 | C17H19ClN6O2 | |
GC38871-100mg |
|
1356992-21-6 |
XL-784 free base
|
0 | C21H22ClF2N3O8S | |
GC38871-50mg |
|
1356992-21-6 |
XL-784 free base
|
0 | C21H22ClF2N3O8S | |